Association analysis between MDR1 gene polymorphisms and risk of hepatocellular carcinoma in Chinese population

References

• Amarapurkar DN, Patel ND, Kamani PM. (2008). Impact of diabetes mellitus on outcome of HCC. Ann Hepatol 7:148–51
   Google Scholar
• Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. (2003). P-glycoprotein: from genomics to mechanism. Oncogene 22:7468–85
   PubMed Web of Science ®Google Scholar
• Bosch FX, Ribes J, Diaz M, Cleries R. (2004). Primary liver cancer: worldwide incidence and trends. Gastroenterology 127:S5–16
   PubMed Web of Science ®Google Scholar
• Cavaco I, Gil JP, Gil-Berglund E, Ribeiro V. (2003). CYP3A4 and MDR1 alleles in a Portuguese population. Clin Chem Lab Med 41:1345–50
   PubMedGoogle Scholar
• Chen JG, Zhang SW, Chen WQ. (2010). Analysis of liver cancer mortality in the national retrospective sampling survey of death causes in China, 2004–2005. Zhonghua Yu Fang Yi Xue Za Zhi 44:383–9
   Google Scholar
• Chen XJ, Wang XG, Shen YJ, et al. (2011). Correlation of MDR1 single nucleotide polymorphism with prognosis of hepatocellular carcinoma. J Chin Oncol 17:209–11
   Google Scholar
• Chen YD, Yang F, Feng ST, Zhang YX. (2009). A case-control study on the association between genetic polymorphisms of MDR1 and hepatic cell cancer susceptibility. Chin Clin Oncol 14:1077–81
   Google Scholar
• Chinn LW, Kroetz DL. (2007). ABCB1 pharmacogenetics: progress, pitfalls, and promise. Clin Pharmacol Ther 81:265–9
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Rudolph KL. (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–76
   PubMed Web of Science ®Google Scholar
• Farazi PA, DePinho RA. (2006). Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6:674–87
   PubMed Web of Science ®Google Scholar
• Fromm MF. (2002). Genetically determined differences in P-glycoprotein function: implications for disease risk. Toxicology 181–182:299–303
   PubMed Web of Science ®Google Scholar
• Gomaa AI, Khan SA, Toledano MB, et al. (2008). Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 14:4300–8
   PubMed Web of Science ®Google Scholar
• Goto M, Masuda S, Kiuchi T, et al. (2008). Relation between mRNA expression level of multidrug resistance 1/ABCB1 in blood cells and required level of tacrolimus in pediatric living-donor liver transplantation. J Pharmacol Exp Ther 325:610–16
   PubMed Web of Science ®Google Scholar
• Haliassos A, Chomel JC, Tesson L, et al. (1989). Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res 17:3606
   PubMed Web of Science ®Google Scholar
• Hoffmeyer S, Burk O, von Richter O, et al. (2000). Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 97:3473–8
   PubMed Web of Science ®Google Scholar
• Jamroziak K, Mlynarski W, Balcerczak E, et al. (2004). Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol 72:314–21
   PubMed Web of Science ®Google Scholar
• Kaya P, Gunduz U, Arpaci F, et al. (2005). Identification of polymorphisms on the MDR1 gene among Turkish population and their effects on multidrug resistance in acute leukemia patients. Am J Hematol 80:26–34
   PubMed Web of Science ®Google Scholar
• Kimchi-Sarfaty C, Oh JM, Kim IW, et al. (2007). A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science 315:525–8
   PubMed Web of Science ®Google Scholar
• Kurzawski M, Drozdzik M, Suchy J, et al. (2005). Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. Eur J Clin Pharmacol 61:389–94
   Google Scholar
• Leonessa F, Clarke R. (2003). ATP binding cassette transporters and drug resistance in breast cancer. Endocr Relat Cancer 10:43–73
   PubMed Web of Science ®Google Scholar
• Llovet JM, Burroughs A, Bruix J. (2003). Hepatocellular carcinoma. Lancet 362:1907–17
   PubMed Web of Science ®Google Scholar
• Marrero JA, Fontana RJ, Fu S, et al. (2005). Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42:218–24
   PubMed Web of Science ®Google Scholar
• Masuda S, Goto M, Fukatsu S, et al. (2006). Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients. Clin Pharmacol Ther 79:90–102
   PubMed Web of Science ®Google Scholar
• Nault JC, Zucman-Rossi J. (2011). Genetics of hepatobiliary carcinogenesis. Semin Liver Dis 31:173–87
   PubMed Web of Science ®Google Scholar
• Parikh S, Hyman D. (2007). Hepatocellular cancer: a guide for the internist. Am J Med 120:194–202
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
   PubMed Web of Science ®Google Scholar
• Pechandova K, Buzkova H, Slanar O, Perlik F. (2006). Polymorphisms of the MDR1 gene in the Czech population. Folia Biol (Praha) 52:184–9
   PubMed Web of Science ®Google Scholar
• Schutte K, Bornschein J, Malfertheiner P. (2009). Hepatocellular carcinoma – epidemiological trends and risk factors. Dig Dis 27:80–92
   PubMed Web of Science ®Google Scholar
• Sohn JW, Lee SY, Lee SJ, et al. (2006). MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancer. Jpn J Clin Oncol 36:137–41
   PubMed Web of Science ®Google Scholar
• Suriawinata A, Xu R. (2004). An update on the molecular genetics of hepatocellular carcinoma. Semin Liver Dis 24:77–88
   PubMedGoogle Scholar
• Taniguchi S, Mochida Y, Uchiumi T, et al. (2003). Genetic polymorphism at the 5′ regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon. Mol Cancer Ther 2:1351–9
   PubMed Web of Science ®Google Scholar
• Thorgeirsson SS, Grisham JW. (2002). Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339–46
   PubMed Web of Science ®Google Scholar
• Vander Borght S, Komuta M, Libbrecht L, et al. (2008). Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin. Liver Int 28:1370–80
   PubMed Web of Science ®Google Scholar
• Wang D, Johnson AD, Papp AC, et al. (2005). Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C > T affects mRNA stability. Pharmacogenet Genomics 15:693–704
   PubMed Web of Science ®Google Scholar
• Wu L, Xu X, Shen J, et al. (2007). MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation. J Surg Oncol 96:62–8
   PubMedGoogle Scholar
• Yu X, Xie H, Wei B, et al. (2011). Association of MDR1 gene SNPs and haplotypes with the tacrolimus dose requirements in Han Chinese liver transplant recipients. PLoS One 6:e25933
   Google Scholar
• Yuan ZR, Li J, Li JY, et al. (2013a). SNPs identification and its correlation analysis with milk somatic cell score in bovine MBL1 gene. Mol Biol Rep 40:7–12
   PubMed Web of Science ®Google Scholar
• Yuan ZR, Li JY, Li J, et al. (2013b). Effects of DGAT1 gene on meat and carcass fatness quality in Chinese commercial cattle. Mol Biol Rep 40:1947–54
   PubMed Web of Science ®Google Scholar
• Yuan ZR, Li J, Zhang LP, et al. (2012). Investigation on BRCA1 SNPs and its effects on mastitis in Chinese commercial cattle. Gene 505:190–4
   PubMed Web of Science ®Google Scholar
• Zeng X, Liu S, Yu H, et al. (2012). DNA repair capacity, DNA-Strand break repair gene polymorphisms, and the incidence of hepatocellular carcinoma in Southwestern Guangxi of China. DNA Cell Biol 31:1384–91
   Google Scholar
• Zhao CJ, Li N, Deng XM. (2003). The establishment of method for identifying SNP genotype by CRS-PCR. Yi Chuan 25:327–9
   PubMedGoogle Scholar
• Zhou SF. (2008). Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38:802–32
   PubMed Web of Science ®Google Scholar